F16.92 Hallucinogen use, unspecified with intoxication

Name of the Condition

• Hallucinogen Use, Unspecified with Intoxication
• Medical Term: ICD-10-CM F16.92

Summary

Hallucinogen use, unspecified with intoxication refers to the use of hallucinogenic substances resulting in clinically significant intoxication, where the specific pattern of use is not detailed. This code is applied when documentation confirms hallucinogen exposure and associated intoxication symptoms, but does not specify abuse, dependence, or withdrawal. It is used for cases where intoxication is present without further classification of the use pattern.

Causes

Hallucinogen use, unspecified with intoxication typically involves substances that alter perception, mood, or cognitive function, such as LSD, psilocybin, or mescaline. Intoxication occurs due to recent use, leading to temporary physiological and psychological effects. The documentation does not specify a problematic pattern beyond the acute intoxication episode.

Risk Factors

• Recreational or experimental use of hallucinogens
• Pre-existing mental health conditions
• Genetic predisposition to substance use disorders
• Social or peer pressure to use drugs
• Access to hallucinogenic substances

Symptoms

• Altered sensory perceptions (e.g., visual or auditory hallucinations)
• Distorted sense of reality or time
• Mood changes, including euphoria or anxiety
• Impaired judgment or coordination
• Tachycardia or elevated blood pressure
• Nausea or vomiting

Diagnosis

Diagnosis requires clinical documentation of hallucinogen use and associated intoxication symptoms. Healthcare providers assess for acute effects, such as perceptual changes or physiological signs, and rule out other causes. The code is assigned when intoxication is confirmed but the use pattern remains unspecified.

Treatment Options

Treatment focuses on managing acute intoxication symptoms, such as supportive care for agitation or cardiovascular effects. In severe cases, hospitalization may be necessary. Long-term management may involve counseling or referral to substance use disorder programs if dependence is suspected.

Prognosis and Follow-Up

Prognosis depends on the severity of intoxication and any underlying conditions. Most acute episodes resolve with supportive care, but repeated use increases risks of complications. Follow-up may include monitoring for recurrence or development of substance use disorders.

Complications

• Severe psychological distress (e.g., panic or paranoia)
• Accidental injury due to impaired coordination
• Cardiovascular events (e.g., hypertension or arrhythmias)
• Persistent perceptual changes (e.g., hallucinogen persisting perception disorder)

Lifestyle & Prevention

Avoiding hallucinogen use reduces risk. Education on substance effects and healthy coping strategies may help prevent initiation. For those with a history of use, avoiding triggers and seeking support can minimize recurrence.

When to Seek Professional Help

Seek help if intoxication symptoms are severe (e.g., extreme agitation, chest pain) or if use becomes frequent. Persistent psychological effects or inability to stop use also warrant evaluation.

Tips for Medical Coders

Document the presence of hallucinogen use and intoxication symptoms clearly. Ensure the code F16.92 is used when intoxication is confirmed but the use pattern is unspecified. Avoid this code if abuse, dependence, or withdrawal is documented, as more specific codes apply.